According to a ranking by Statista and Newsweek, the best hospital in the United States is the Mayo Clinic in Rochester, Minnesota. Moreover, the Mayo Clinic was also ranked as the best hospital in the world, among over 50,000 hospitals in 30 countries. Cleveland Clinic in Ohio and the Johns Hopkins Hospital in Maryland were ranked as second and third best respectively in the U.S., while they were second and forth best respectively in the World.

This dataset shows the the world's best hospital in 2023 issued by the Newsweek and Statista.

According to a ranking of the best hospitals in the U.S., the best hospital for adult cancer is the University of Texas MD Anderson Cancer Center, which had a score of 100 out of 100, as of 2024. This statistic shows the top 10 hospitals for adult cancer in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

As of 2022, the largest hospital in the world was found in Henan, China. With seven thousand beds, First Affiliated Hospital of Zhengzhou University was ranked as the largest hospital globally according to its number of beds. The second largest hospital was also found in China. No U.S. hospital made the world top 20 list, although AdventHealth Orlando was close, being the largest hospital in the United States.

The average for 2020 based on 4 countries was 8.29 hospital beds. The highest value was in South Korea: 12.65 hospital beds and the lowest value was in Israel: 2.92 hospital beds. The indicator is available from 1960 to 2021. Below is a chart for all countries where data are available.

According to a ranking by Statista and Newsweek, the best hospital in Denmark is the Rigshospitalet - København in Copenhagen. Moreover, the Rigshospitalet - København was also ranked as the 21st best hospital in the world, among over 50,000 hospitals in 30 countries. Aarhus Universitetshospital in Aarhus and Odense Universitetshospital in Odense were ranked as second and third best respectively in the Denmark, while they were 23rd and 85th best respectively in the World.

*Standardized units.Characteristics of the top 50 Cancer Hospitals, as ranked by the US News and World Report.

According to a ranking by Statista and Newsweek, the best hospital in Sweden is the Karolinska Universitetssjukhuset in Stockholm. Moreover, Karolinska Universitetssjukhuset was also ranked as the seventh-best hospital in the world, among over 50,000 hospitals in 30 countries. Sahlgrenska Universitetssjukhuset in Göteborg and Akademiska Sjukhuset in Uppsala were ranked as second and third best respectively in the Sweden, while they were 74th and 75th best respectively in the World.

According to a ranking of the best hospitals in the U.S., the best hospital for adult cardiology, heart, and vascular surgery is the Cleveland Clinic in Ohio, which had a score of 100 out of 100, as of 2024. This statistic shows the top 10 hospitals for adult cardiology, heart, and vascular surgery in the United States based on the score given by U.S. News and World Report's annual hospital ranking.

According to a ranking by Statista and Newsweek, the best hospital in Norway is Oslo Universitetssykehus in Oslo. Moreover, Oslo Universitetssykehus was also ranked as the 29th best hospital in the world, among over 50,000 hospitals in 30 countries. St. Olavs Hospital in Trondheim and Haukeland Universitetssykehus in Bergen were ranked as second and third best respectively in the Norway, while they were 138th and 151st best respectively in the World.

ContextPrior research has faulted the US News and World Report hospital specialty rankings for excessive reliance on reputation, a subjective measure of a hospital's performance.ObjectiveTo determine whether and to what extent reputation correlates with objective measures of research productivity among cancer hospitals.DesignA retrospective observational study.SettingAutomated search of NIH Reporter, BioEntrez, BioMedline and Clinicaltrials.gov databases.ParticipantsThe 50 highest ranked cancer hospitals in 2013's US News and World Report Rankings.ExposureWe ascertained the number of NCI funded grants, and the cumulative funds received by each cancer center. Additionally, we identified the number of phase I, phase II, and phase III studies published and indexed in MEDLINE, and registered at clinicaltrials.gov. All counts were over the preceding 5 years. For published articles, we summed the impact factor of the journals in which they appeared. Trials were attributed to centers on the basis of the affiliation of the lead author or study principal investigator.Main OutcomeCorrelation coefficients from simple and multiple linear regressions for measures of research productivity and a center's reputation.ResultsAll measures of research productivity demonstrated robust correlation with reputation (mean r-squared  = 0.65, median r-squared = 0.68, minimum r-squared = .41, maximum r-squared = 0.80). A multivariable model showed that 93% of the variation in reputation is explained by objective measures.ConclusionContrary to prior criticism, the majority of reputation, used in US News and World Rankings, can be explained by objective measures of research productivity among cancer hospitals.

South Korea Number of Hospital was up 3.5% in 2019, compared to the previous year.

The average for 2020 based on 36 countries was 356986 hospital beds. The highest value was in China: 7131200 hospital beds and the lowest value was in Iceland: 1039 hospital beds. The indicator is available from 1960 to 2021. Below is a chart for all countries where data are available.

According to a ranking by Statista and Newsweek, the best hospital in Finland is Helsinki University Hospital in Helsinki. Moreover, Helsinki University Hospital was also ranked as the 50th best hospital in the world, among over 50,000 hospitals in 30 countries. Tampere University Hospital in Tampere and Turku University Hospital in Turku were ranked as second and third best respectively in the Finland, while they were 126th and 121st best respectively in the World.

Correlation coefficients (R2) from simple linear regressions between the US News and World Report Score and its contributors.

ContextResearch-oriented cancer hospitals in the United States treat and study patients with a range of diseases. Measures of disease specific research productivity, and comparison to overall productivity, are currently lacking.HypothesisDifferent institutions are specialized in research of particular diseases.ObjectiveTo report disease specific productivity of American cancer hospitals, and propose a summary measure.MethodWe conducted a retrospective observational survey of the 50 highest ranked cancer hospitals in the 2013 US News and World Report rankings. We performed an automated search of PubMed and Clinicaltrials.gov for published reports and registrations of clinical trials (respectively) addressing specific cancers between 2008 and 2013. We calculated the summed impact factor for the publications. We generated a summary measure of productivity based on the number of Phase II clinical trials registered and the impact factor of Phase II clinical trials published for each institution and disease pair. We generated rankings based on this summary measure.ResultsWe identified 6076 registered trials and 6516 published trials with a combined impact factor of 44280.4, involving 32 different diseases over the 50 institutions. Using a summary measure based on registered and published clinical trails, we ranked institutions in specific diseases. As expected, different institutions were highly ranked in disease-specific productivity for different diseases. 43 institutions appeared in the top 10 ranks for at least 1 disease (vs 10 in the overall list), while 6 different institutions were ranked number 1 in at least 1 disease (vs 1 in the overall list).ConclusionResearch productivity varies considerably among the sample. Overall cancer productivity conceals great variation between diseases. Disease specific rankings identify sites of high academic productivity, which may be of interest to physicians, patients and researchers.

In 2023, Singapore dominated the ranking of the world's health and health systems, followed by Japan and South Korea. The health index score is calculated by evaluating various indicators that assess the health of the population, and access to the services required to sustain good health, including health outcomes, health systems, sickness and risk factors, and mortality rates. The health and health system index score of the top ten countries with the best healthcare system in the world ranged between 82 and 86.9, measured on a scale of zero to 100.

Global Health Security Index  Numerous health and health system indexes have been developed to assess various attributes and aspects of a nation's healthcare system. One such measure is the Global Health Security (GHS) index. This index evaluates the ability of 195 nations to identify, assess, and mitigate biological hazards in addition to political and socioeconomic concerns, the quality of their healthcare systems, and their compliance with international finance and standards. In 2021, the United States was ranked at the top of the GHS index, but due to multiple reasons, the U.S. government failed to effectively manage the COVID-19 pandemic. The GHS Index evaluates capability and identifies preparation gaps; nevertheless, it cannot predict a nation's resource allocation in case of a public health emergency.

Universal Health Coverage Index  Another health index that is used globally by the members of the United Nations (UN) is the universal health care (UHC) service coverage index. The UHC index monitors the country's progress related to the sustainable developmental goal (SDG) number three. The UHC service coverage index tracks 14 indicators related to reproductive, maternal, newborn, and child health, infectious diseases, non-communicable diseases, service capacity, and access to care. The main target of universal health coverage is to ensure that no one is denied access to essential medical services due to financial hardships. In 2021, the UHC index scores ranged from as low as 21 to a high score of 91 across 194 countries. 

Hospitals play a critical role in healthcare, offering specialized treatments and emergency services essential for public health, regardless of economic fluctuations or individuals' financial situations. Rising incomes and broader access to insurance have fueled demand for care in recent years, supporting hospitals' post-pandemic recovery initiated by federal policies and funding. The recovery for many hospitals was also promoted by mergers that lessened financial strains, especially in rural hospitals. This trend toward consolidation has resulted in fewer enterprises relative to establishments, enhancing hospitals' bargaining power regarding input costs and insurance reimbursements. With this improved position, hospitals are expected to see revenue climb at a CAGR of 2.0%, reaching $1.5 trillion by 2025, with a 3.2% increase in 2025 alone. Competition, economic conditions and regulatory changes will impact hospitals based on size and location. Smaller hospitals, particularly rural ones, may encounter more significant obstacles as the industry transitions from fee-based to value-based care. Independent hospitals face wage inflation, staffing shortages and drug supply costs. Although state and federal policies aim to support small rural hospitals in addressing hospital deserts, uncertainties linger over federal Medicare funding and Medicaid reimbursements, which account for nearly half of hospital care spending. Even so, increasing per capita disposable income and increasing the number of individuals with private insurance will boost revenues from private insurers and out-of-pocket payments for all hospitals, big and small. Hospitals will continue incorporating technological advancements in AI, telemedicine and wearables to enhance their services and reduce cost. These technologies aid hospital systems in strategically expanding outpatient services, mitigating the increasing competitive pressures from Ambulatory Surgery Centers (ASCs) and capitalizing on the increased needs of an aging adult population and shifts in healthcare delivery preferences. As the consolidation trend advances and technology adoption further leverages economies of scale, industry revenue is expected to strengthen at a CAGR of 2.4%, reaching $1.7 trillion by 2030, with steady profit over the period.

IntroductionIn confronting the sudden COVID-19 epidemic, China and other countries have been under great pressure to block virus transmission and reduce fatalities. Converting large-scale public venues into makeshift hospitals is a popular response. This addresses the outbreak and can maintain smooth operation of a country or region's healthcare system during a pandemic. However, large makeshift hospitals, such as the Shanghai New International Expo Center (SNIEC) makeshift hospital, which was one of the largest makeshift hospitals in the world, face two major problems: Effective and precise transfer of patients and heterogeneity of the medical care teams.MethodsTo solve these problems, this study presents the medical practices of the SNIEC makeshift hospital in Shanghai, China. The experiences include constructing two groups, developing a medical management protocol, implementing a multi-dimensional management mode to screen patients, transferring them effectively, and achieving homogeneous quality of medical care. To evaluate the medical practice performance of the SNIEC makeshift hospital, 41,941 infected patients were retrospectively reviewed from March 31 to May 23, 2022. Multivariate logistic regression method and a tree-augmented naive (TAN) Bayesian network mode were used.ResultsWe identified that the three most important variables were chronic disease, age, and type of cabin, with importance values of 0.63, 0.15, and 0.11, respectively. The constructed TAN Bayesian network model had good predictive values; the overall correct rates of the model-training dataset partition and test dataset partition were 99.19 and 99.05%, respectively, and the respective values for the area under the receiver operating characteristic curve were 0.939 and 0.957.ConclusionThe medical practice in the SNIEC makeshift hospital was implemented well, had good medical care performance, and could be copied worldwide as a practical intervention to fight the epidemic in China and other developing countries.

Hospital Price Transparency Platform Market Outlook

According to our latest research, the global hospital price transparency platform market size in 2024 stands at USD 1.24 billion, reflecting the rapid adoption of digital solutions for healthcare cost management and regulatory compliance. The market is projected to expand at a robust CAGR of 13.2% from 2025 to 2033, reaching an estimated value of USD 3.61 billion by the end of the forecast period. This significant growth is primarily driven by stringent government regulations mandating transparent healthcare pricing, increasing patient demand for price clarity, and the ongoing digital transformation across healthcare systems worldwide.

A major growth factor for the hospital price transparency platform market is the global push for regulatory compliance, particularly in the United States, where the Centers for Medicare & Medicaid Services (CMS) have implemented rules requiring hospitals to disclose standard charges and negotiated rates. This regulatory landscape compels healthcare providers to adopt sophisticated price transparency platforms, ensuring compliance while avoiding hefty penalties. Furthermore, these platforms facilitate the seamless management and dissemination of complex pricing data, reducing administrative burdens and enhancing operational efficiency. As a result, hospitals and healthcare organizations are increasingly investing in advanced software and services that streamline compliance and foster trust with patients.

Another key driver is the growing consumerization of healthcare, with patients seeking more control over their medical expenses. The rise of high-deductible health plans and increased out-of-pocket costs have made patients acutely aware of healthcare pricing. Hospital price transparency platforms empower patients by providing real-time access to pricing information, enabling informed decision-making and fostering competition among providers. This shift towards patient-centric care is further amplified by digital health trends, with mobile applications and web-based portals making price comparison and financial planning more accessible than ever before. Consequently, healthcare organizations are leveraging these platforms to enhance patient satisfaction and loyalty, gaining a competitive edge in a rapidly evolving market.

Technological advancements and the integration of artificial intelligence (AI) and machine learning (ML) are also propelling the hospital price transparency platform market forward. These technologies enable sophisticated data analytics, predictive modeling, and personalized pricing estimates, addressing the complexities of healthcare billing and reimbursement. AI-powered platforms can automate the extraction, validation, and presentation of pricing data from disparate systems, ensuring accuracy and compliance. Additionally, the adoption of cloud-based deployment models facilitates scalability, data security, and remote access, making these platforms more attractive to healthcare organizations of all sizes. The convergence of regulatory, consumer, and technological trends is thus creating a fertile environment for sustained market growth.

Regionally, North America dominates the hospital price transparency platform market, accounting for the largest share in 2024, followed by Europe and Asia Pacific. The United States is at the forefront due to strict regulatory mandates, high healthcare expenditure, and a mature digital health ecosystem. Europe is witnessing steady growth, driven by increasing healthcare digitization and policy initiatives promoting transparency and patient empowerment. Meanwhile, the Asia Pacific region is emerging as a high-growth market, fueled by expanding healthcare infrastructure, rising adoption of digital health solutions, and growing awareness about healthcare costs. Latin America and the Middle East & Africa are also experiencing gradual uptake, supported by government reforms and investments in health IT. The regional outlook highlights the global momentum towards transparent, efficient, and patient-centric healthcare delivery.